Search clinical trials for: Non-interventional study

Total 119268 results

Astellas Pharma s.r.o.

Completed

A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

Post-operative Peripheral Neuropathic Pain

Czech Republic
Peking Union Medical College Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer (AHEAD-G202)

Metastatic Gastric Cancer

China
iOMEDICO AG

Completed

Non-interventional Study With Azacitidin (Vidaza®) (Piaza)

AML | MDS | CMMOL

Germany
Neuroendocrine Associates P.C.
Columbia University

Unknown

Epilepsy Birth Control Registry (EBCR)

Epilepsy

United States
Bayer

Completed

Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction (Mirabel)

Contraception

Russian Federation
Bayer

Completed

Non-interventional Study on Oral Contraception Not Containing Ethinylestradiol (EE) to Assess Continuation Rates and Satisfaction

Contraceptives, Oral

Slovakia, France, Germany, Hungary, Sweden, Czech Republic, Italy, Russian Federation, United Kingdom, Greece, Israel
Mundipharma AB

Completed

Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives

Pain | Opioid Induced Constipation

Sweden
Bayer

Completed

Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life (DIVA)

Endometriosis

Saudi Arabia, Jordan, Kazakhstan, Lebanon, Russian Federation, Ukraine, Egypt, United Arab Emirates, Kuwait, Qatar, Belarus
H. Lundbeck A/S

Completed

A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder (PERFORM)

Major Depressive Disorder

France
Novo Nordisk A/S

Completed

Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome (NordiPAD)

Turner Syndrome | Growth Hormone Disorder | Growth Hormone Deficiency in Children | Genetic Disorder

Japan
Medice Arzneimittel Pütter GmbH & Co KG

Completed

Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder (IDEA)

Adult Attention-deficit/Hyperactivity Disorder

Germany
Fresenius Medical Care Deutschland GmbH
Siro Clinpharm Germany GmbH

Completed

Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) (Steering)

ESRD | Hyperphosphataemia

United Kingdom, Spain, Denmark, Germany
Boehringer Ingelheim

Completed

Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data

HIV Infections

Germany
Pfizer
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Copenhagen University Hospital at Herlev and other collaborators

Completed

Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.

Renal Cell Carcinoma

Denmark
Boehringer Ingelheim

Completed

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

HIV Infections

Germany
Boehringer Ingelheim

Completed

Non-interventional Observational Study on the Influence of Pramipexole on Sensory Symptoms of Restless Legs Syndrome (RLS)

Restless Legs Syndrome

Germany
Amgen

Completed

Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Thrombocytopenia | Idiopathic Thrombocytopenic Purpura | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenic Purpura
Boehringer Ingelheim

Completed

Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's Disease

Parkinson Disease

Germany
Boehringer Ingelheim

Completed

Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease

Parkinson Disease

Germany
Boehringer Ingelheim

Completed

Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life

Restless Legs Syndrome

Germany
Janssen Korea, Ltd., Korea

Completed

An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients

Pain
Janssen-Cilag S.p.A.

Completed

Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice

HIV Infections
UCB Pharma
Pivotal S.L.

Completed

Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine (RETO-PD)

Parkinson's Disease

Spain
Pfizer

Terminated

Non-Interventional Study To Investigate Whether Information Provided To Patients Influences Their Satisfaction With Toviaz Therapy

Urinary Bladder, Overactive
AstraZeneca

Completed

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

Advanced Breast Cancer
GlaxoSmithKline

Completed

Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath

Pulmonary Disease, Chronic Obstructive

United States
AstraZeneca

Completed

Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia

Schizophrenia | Acute Psychotic Episode

Hungary, Latvia, Romania
UCB Pharma

Completed

Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise (RLS-Practise)

Idiopathic Restless Legs Syndrome

Germany
Pfizer

Completed

Prevenar (PCV-7) Post-Licensure Safety Study In Russia

Healthy Children After Vaccination

Russian Federation
AstraZeneca

Completed

Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors

Hypercholesterolaemia

Croatia
AstraZeneca

Completed

Non-interventional Retrospective Multicenter Study of Patients With Bronchial Asthma During a Routine Visit to Out of Patients' Clinics (NIKA)

Asthma

Russian Federation
AstraZeneca

Completed

Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia (PASQAL)

Quality of Life in Schizophrenia
AstraZeneca

Completed

An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice

Nosocomial Infection

Vietnam
AstraZeneca

Completed

Non-interventional Study to Evaluate the Change in Symptoms Scores and Treatment Response After 4 Weeks of Proton-Pump Inhibitors (PPI) Treatment

Gastroesophageal Reflux

Romania
AstraZeneca

Completed

Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia

Schizophrenia

Croatia
AstraZeneca

Completed

Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR

Schizophrenia

Romania
XDx

Terminated

Lung Allograft Rejection Gene Expression Observational (LARGO) Study (LARGO)

Lung Disease | Graft Rejection

United States, Canada, Germany, Austria, United Kingdom
AstraZeneca
Daiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, Tokyo

Not yet recruiting

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer (DESTINY-BTC01)

Biliary Tract Cancer

Belgium, Canada, Brazil, Japan, Korea, Republic of, Taiwan, Germany, Austria, Netherlands
Amgen

Not yet recruiting

A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD)

End-Stage Renal Disease (ESRD)
Loci Orthopaedics

Not yet recruiting

Thumb Hemi-Arthroplasty With Natural Kinematics; a Prospective Multicenter Study to Confirm the Safety and Efficacy of the InDx Implant (THANKS PRO)

CMC Joint Arthritis
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Safety and Adequacy of Trans-jugular Liver Biopsy in Patients With Liver Disease: SAFE-TJLB Study

Liver Cirrhosis

India
Chinese University of Hong Kong

Recruiting

Boiled Tree Nut for Oral Immunotherapy in Food-allergic Children

Food Allergy | Food Allergy in Children

Hong Kong
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response: A Multi-center Prospective Study

Respiratory Tract Infections | Pneumonia, Ventilator-Associated | Prognosis

China
Pfizer
Aptar Digital Health

Not yet recruiting

A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults. (CONFIDENCE)

Migraine
Fujian Cancer Hospital

Not yet recruiting

Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma
Tang-Du Hospital

Recruiting

Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

Small Cell Lung Cancer

China
Grupo Espanol de Trabajo en Enfermedad de Crohn...
Pfizer

Recruiting

An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU) (PASS TOFA)

Ulcerative Colitis

Belgium, Bulgaria, Greece, Lithuania
AbbVie

Not yet recruiting

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa
Yale University
National Institute on Deafness and Other Communication Disorders (NIDCD)

Not yet recruiting

Speech Motor Learning and Retention (Aim 1)

Speech

United States
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study of IBI363 in Subjects With Advanced Malignancies

Advanced Malignancies

China

3

Subscribe